|
1）Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol. 2006; 17: 17-25
|
|
|
|
2）Tanaka T, Nangaku M. Angiogenesis and hypoxia in the kidney. Nat Rev Nephrol. 2013; 9: 211-22
|
|
|
|
|
3）Ishani A, Xue JL, Himmelfarb J, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009; 20: 223-8
|
|
|
|
|
|
4）Basile DP, Donohoe D, Osborn JL, et al. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol. 2001; 281: F887-99
|
|
|
|
|
|
5）Ishii Y, Sawada T, Shimizu A. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int. 2005; 67: 321-32
|
|
|
|
|
|
6）Krüger B, Krick S, Schröppel B, et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A. 2009; 106: 3390-5
|
|
|
|
|
|
7）Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 2007; 72: 151-6
|
|
|
|
|
|
8）Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell. 2011; 146: 873-87
|
|
|
|
|
|
9）Phng LK, Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev Cell. 2009; 16: 196-208
|
|
|
|
|
|
10）Augustin HG, Koh GY, Alitalo K, et al. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol. 2009; 10: 165-77
|
|
|
|
|
|
11）Jakobsson L, Franco CA, Gerhardt H, et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat Cell Biol. 2010; 12: 943-53
|
|
|
|
|
|
12）Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012; 148: 399-408
|
|
|
|
|
|
13）Rosenberger C, Mandriota S, Eckardt KU, et al. Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol. 2002; 13: 1721-32
|
|
|
|
|
|
14）Tang N, Wang L, Johnson RS, et al. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell. 2004; 6: 485-95
|
|
|
|
|
|
15）Skuli N, Liu L, Keith B, et al. Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis. Blood. 2009; 114: 469-77
|
|
|
|
|
|
16）Skuli N, Majmundar AJ, Simon MC, et al. Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes. J Clin Invest. 2012; 122: 1427-43
|
|
|
|
|
|
17）Lee S, Chen TT, Iruela-Arispe ML, et al. Autocrine VEGF signaling is required for vascular homeostasis. Cell. 2007; 130: 691-703
|
|
|
|
|
|
18）Jin J, Sison K, Quaggin SE, et al. Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell. 2012; 151: 384-99
|
|
|
|
|
|
19）Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A. 2002; 99: 11205-10
|
|
|
|
|
|
20）Kang DH, Joly AH, Johnson RJ, et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol. 2001; 12: 1434-47
|
|
|
|
|
|
21）Lin SL, Chang FC, Duffield JS, et al. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am J Pathol. 2011; 178: 911-23
|
|
|
|
|
|
22）Basile DP, Zeng P, Yoder MC, et al. Low proliferative potential and impaired angiogenesis of cultured rat kidney endothelial cells. Microcirculation. 2012; 19: 598-609
|
|
|
|
|
|
23）Chen YT, Chang FC, Lin SL, et al. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int. 2011; 80: 1170-81
|
|
|
|
|
|
24）Schrimpf C, Xin C, Duffield JS, et al. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol. 2012; 23: 868-83
|
|
|
|
|
|
25）Foo SS, Turner CJ, Adams RH, et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell. 2006; 124: 161-73
|
|
|
|
|
|
26）Sawamiphak S, Seidel S, Acker-Palmer A, et al. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature. 2010; 465: 487-91
|
|
|
|
|
|
27）Kida Y, Ieronimakis N, Duffield JS, et al. EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury. J Am Soc Nephrol. 2013; 24: 559-72
|
|
|
|
|
|
28）Stenzel D, Franco CA, Gerhardt H, et al. Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo. EMBO Rep. 2011; 12: 1135-43
|
|
|
|
|
|
29）Kang DH, Hughes J, Johnson RJ, et al. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol. 2001; 12: 1448-57
|
|
|
|
|
|
30）Kim W, Moon SO, Park SK, et al. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J Am Soc Nephrol. 2006; 17: 2474-83
|
|
|
|
|
|
31）Gupta R, Tongers J, Losordo DW. Human studies of angiogenic gene therapy. Circ Res. 2009; 105: 724-36
|
|
|
|
|
|
32）Matsumoto M, Makino Y, Nangaku M, et al. Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol. 2003; 14: 1825-32
|
|
|
|
|
|
33）Tanaka T, Kojima I, Nangaku M, et al. Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. Lab Invest. 2005; 85: 1292-307
|
|
|
|
|
|
34）Leite de Oliveira R, Deschoemaeker S, Mazzone M, et al. Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity. Cancer Cell. 2012; 22: 263-77
|
|
|
|
|
|
35）Nangaku M, Tanaka T. Forewarned is forearmed: arm with HIF activation. Nephrol Dial Transplant. 2010; 25: 1385-7
|
|
|
|
|
|
36）Bernhardt WM, Gottmann U, Eckardt KU, et al. Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sci U S A. 2009; 106: 21276-81
|
|
|
|
|
|
37）Sarkar K, Fox-Talbot K, Semenza GL, et al. Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci U S A. 2009; 106: 18769-74
|
|
|
|
|
|
38）Jiang X, Khan MA, Nicolls MR, et al. Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection. J Clin Invest. 2011; 121: 2336-49
|
|
|
|
|
|
39）Kojima I, Tanaka T, Nangaku M, et al. Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney. J Am Soc Nephrol. 2007; 18: 1218-26
|
|
|
|
|
|
40）Mazzone M, Dettori D, Carmeliet P, et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell. 2009; 136: 839-51
|
|
|
|
|